Nepal Cancer Hospital Thanks PM Modi for Gifting Teletherapy Machine

Published On 2018-05-15 05:09 GMT   |   Update On 2018-05-15 05:09 GMT

Kathmandu: India gifting a Bhabhatron radioactive teletherapy machine to Nepal's leading cancer hospital would be hugely beneficial to thousands of cancer patients waiting for treatment in the Himalayan nation, a top hospital official has said.


Prime Minister Narendra Modi, who was on a state visit to Nepal, announced on Friday that the Indian government would gift Bhabhatron Radioactive Cobalt-60 teletherapy machine to Bhaktapur Cancer Hospital in Kathmandu.

"Bhabhatron Cobalt therapy is the medical use of gamma rays from the radioisotope cobalt-60 to treat cancer," said Ishwor Shrestha, director at Bhaktapur Cancer Hospital.


"The hospital was in need of radiotherapy machine for treatment of cancer. There is only one Cobalt-60 radiotherapy machine in the hospital and additional gift would help provide timely treatment to cancer patients," he was quoted as saying by The Himalayan Times.


Thanking Indian Prime Minister Modi, Shrestha said the number of patients at the hospital had been increasing, but they had to wait for months to receive treatment.


There are nearly 200 patients at the hospital waiting for the last three months to receive treatment.

He said the hospital had earlier requested the Indian embassy to provide the machine. The machine costs Rs 1,200,000, the report said.

Bhabhatron telecobalt machines were developed by scientists at the Bhabha Atomic Research Centre to meet the demand for affordable cancer treatment machines. Compared to imported telecobalt machines, the indigenous machines are cheaper and have superior features, according to BARC scientists.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News